Keith R. Carlton

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA.

MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA.

Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Goodwin Procter LLP is a law firm which provides advice to companies in public and private enterprises. It provides services to financial, life sciences, private equity, real estate, and technolgy industries. The company was founded in 1912 and is headquartered in Boston, MA.

Respicardia, Inc. is a holding company, which engages in the provision of cardiovascular ultra-sound diagnostic devices. The company was founded by Theodore C. Skokos, Mark Gelfand, Dr. Howard R. Levin and Dr. Danny Sachs in 2006 and is headquartered in Minnetonka, MN.

CardioFocus, Inc. engages in the development and market of catheter-based approach to treating atrial fibrillation. The company was founded by Edward Sinofsky in 1990 and is headquartered in Marlborough, MA.

SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston.

Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN.

Creganna Tactx Singapore Ltd. develops and manufactures medical devices. Its services include designing, developing, manufacturing and delivering finished medical devices; clinical, regulatory support and supply chain solution. The company was founded by Ian Quinn in 1980 and is headquartered in Galway, Ireland.

BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada.

Part of Sandvik Aktiebolag, Medtronic, Inc. (Tennessee) is a company that manufactures instruments for spinal surgery. The company is based in Memphis, TN. Medtronic, Inc. (Tennessee was acquired by Sandvik Materials Technology AB on December 21, 2007.

Part of Medtronic Plc, Medtronic USA, Inc. distributes medical devices. The company is based in Minneapolis, MN. The CEO of the company is Douglas A. Hoekstra.

Ximedica LLC provides medical technology services. It develops endoscopic devices, laparoscopic tools, emergency care systems, infusion systems, urologic ablation and blood management devices. The company was founded by Stephen Lane and Aidan Petrie in 1985 and is headquartered in Providence, RI.

Creganna-Tactx Medical, Inc. provides products, technologies and services to medical device companies. Its offers design services, clinical and regulatory support, pilot and volume manufacturing, and supply chain solutions. The company was founded in 2010 and is headquartered in Campbell, CA.

CarePredict, Inc. offers wearable tech for seniors. It provides Tempo, a wrist-worn sensor that identifies and monitors a senior?s activities of daily living, as well as helps senior living staff and home care providers to identify the changes in daily activities that are precursors to serious health concerns. The company was founded by Satish Movva and Krishna Vedala in 2013 and is headquartered in Plantation, FL.

CardioSolv Ablation Technologies, Inc. develops cardiac modelling system to improve patient outcomes and reducing cardiology procedural time. The company was founded in and is headquartered in Baltimore, MD.

Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD.

Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA.

NeuroAccess Technologies, Inc. develops spinal cord stimulation therapies and technologies for chronic pain patients who are failed candidates for traditional chronic SCS implant procedures. The company was founded by Vince P. Owens, Scott Kokones, Nandan Lad, Greg Schulte, and Andrew D. Firlik in 2012 and is headquartered in Boston, MA.

Giiant Pharma, Inc. is a Canadian preclinical-stage biotech company that specializes in designing gut-restricted small molecule drug therapeutics with various biological targets in gastroenterology. The company is based in Montréal, Canada and was founded by Elizabeth Elizabeth Kwong. The company's proprietary precision delivery technology platform allows for the creation of tissue-specific drugs with improved tolerability and enhanced therapeutic effects. Giiant's first lead program, GT-2108, is a microbiota-activated PDE4 inhibitor prodrug. Maxime Ranger has been the CEO of the company since 2021.